Senators Provide a Roadmap for AI Policy in the US

The Bipartisan Senate AI Working Group released a roadmap for AI policy in the U.S. Senate, encouraging the Senate Appropriations Committee to fund cross-government artificial intelligence research and development projects, including research for biotechnology and applications of AI that would fundamentally transform medicine. The group acknowledges AI's various use cases, including those within the healthcare setting, such as improving disease diagnosis, developing new medicines and assisting providers in various capacities. Senators wrote that relevant committees should consider implementing legislation that supports AI deployment in the sector. They should also implement guardrails and safety measures to ensure patient safety while ensuring the regulations do not stifle innovation.

Medigy Insights

The roadmap states that committees should support the National Institutes of Health (NIH) in developing and improving AI technologies as well, specifically regarding data governance and making data available for science and machine learning research while ensuring patient privacy. Department of Health and Human Services (HHS) agencies, like the Food and Drug Administration (FDA) and the Office of the National Coordinator for Health Information Technology, should also be provided with tools to effectively determine the benefits and risks of AI-enabled products so developers can adhere to a predictable regulatory structure.

Continue reading at mobihealthnews.com

Make faster decisions with community advice

Deploy this technology today

Reactions to the Ascension Healthcare Ransomware Attack and Suggestions for Healthcare Organizations

The Ascension health system data breach can’t be easily separated from the United Healthcare Change Health breach that recently caused a huge financial and medical impact across the healthcare sector …

Posted May 17, 2024